(0.07%) 5 217.50 points
(0.07%) 39 053 points
(0.05%) 18 209 points
(-1.01%) $77.59
(0.36%) $2.22
(-0.19%) $2 319.80
(-0.16%) $27.50
(-0.21%) $986.30
(0.15%) $0.931
(0.33%) $10.94
(0.21%) $0.801
(0.21%) $91.63
5 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 10.09%
7.43% $ 0.217
Live Chart Being Loaded With Signals
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors...
Stats | |
---|---|
Dzisiejszy wolumen | 245 915 |
Średni wolumen | 233 263 |
Kapitalizacja rynkowa | 2.31M |
EPS | $0 ( 2024-04-01 ) |
Następna data zysków | ( $-2.40 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0200 |
ATR14 | $0.00500 (2.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Mahery Amy | Buy | 17 500 | Restricted Stock Units |
2024-04-08 | Mahery Amy | Buy | 17 500 | Option to purchase common stock |
2024-04-08 | Keyes Jeffry R. | Buy | 17 500 | Restricted Stock Units |
2024-04-08 | Keyes Jeffry R. | Buy | 17 500 | Option to purchase common stock |
2024-04-08 | Gumulka Jerzy | Buy | 17 500 | Restricted Stock Units |
INSIDER POWER |
---|
95.27 |
Last 96 transactions |
Buy: 4 147 286 | Sell: 1 591 936 |
Wolumen Korelacja
CNS Pharmaceuticals Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
UXIN | 0.972 |
RNAZ | 0.962 |
VVOS | 0.958 |
TDAC | 0.958 |
ATHX | 0.956 |
WINT | 0.956 |
EVOK | 0.954 |
AGIL | 0.949 |
GAINL | 0.947 |
THMO | 0.941 |
10 Najbardziej negatywne korelacje | |
---|---|
BOCH | -0.96 |
HCCI | -0.953 |
CCRC | -0.951 |
DSPG | -0.945 |
TVTY | -0.944 |
STAY | -0.942 |
XM | -0.938 |
SHSP | -0.937 |
ORTX | -0.93 |
FSEA | -0.928 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CNS Pharmaceuticals Inc Korelacja - Waluta/Towar
CNS Pharmaceuticals Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-4 134.00 (0.00 %) |
EPS: | $-5.00 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-4 134.00 (0.00 %) |
EPS: | $-5.00 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-11 756.00 (0.00 %) |
EPS: | $-11.22 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-15.34 |
Financial Reports:
No articles found.
CNS Pharmaceuticals Inc
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej